BSEInsider Trading / SAST2d ago · 23 Sept 2026, 11:48 am

Intimation of Closure of Trading Window.

ANG Lifesciences India Ltd · 540694

✦ AI Summary

ANG Lifesciences India Ltd has announced the closure of its trading window from 01 October, 2026, until 48 hours after the declaration of its unaudited standalone and consolidated financial results for the quarter and half year ended 30 September, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

ANG Lifesciences India Ltd - 540694 - Closure of Trading Window

Attachments (1)

📄

dd72dff8-57bc-48aa-a87d-16eaf7ca864f.pdf

pdf

Download →
View document text
CIN No:- L24230PB2006PLC030341 A GST No:- 02AAHCA5390H2ZT ANG LIFESCIENCES "I NDIALIMITED o o, A2 42723 Date. 1409204, Department of Corporate Services BSE Limited P J Tower, Dalal Street Mumbai-400001 Subject- Intimation Regarding Closure of Trading window BSE Security Code: 540694 Dear Sir/ Ma’am, We would like to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended form time to time read with Company’s Code of conduct to regulate, monitor and report the trading of equity shares. The trading window for dealing in the securitieosf the Company shall remain closed from 01 October, 2026 for the insider, designated persons of the company and their immediate relatives, till the end of 48 hours after declaration of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30" September, 2026 Accordingly, all Designated Persons and their Inmediate Relatives of the Company are being advised not to'trade in the securities of the Company during the afo(]esaid period of closure of the Trading Window. The date of Board Meeting for consideration of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30" September, 2026 shall be intimated separately. Kindly take this information on your record. DIN: 01423407